Biotech Values

[bridgeofsighs]

ANPI. I am just stunned that people are so clueless about what is going on.

http://messages.finance.yahoo.com/Stocks_(A_to_Z)/Stocks_A/threadview?m=tm&bn=1098&tid=11625&mid=11625&tof=2&frt=2

-existing Stentprices will have to be lowered dramatically if they are to compete at all. After all, who wants to save money during a procedure on their hearts?!

Currently stents are going for around $2100 per unit (see link) with an average of 1.7 stents implanted per patient and over 1 million procedures done each year in the US alone.
http://online.wsj.com/article/BT-CO-2009...

It doesnt take a math major to figure it out. Perhaps this might be a good opportunity to do some shorting in JNJ, MDT and STJ - a good portion of their stent business is now obsolete.

Similarly, this might be a great time to jump into BSX, a company that has waited for this for quite some time. But of course, you get far more bang for your buck right here in ANPI for anything under $10 per share.